In this study, we found that heparan sulfate proteoglycan 2 (perlecan) (HSPG2), syndecan-1 (SCD1), clathrin (CLTC), and dynamin (DNM1) were present in all patient-derived glioma cells. This evidence concerns the gene CLTC and central nervous system cancer.